k 2023

Targeting undruggable oncoproteins c-Myc and N-Myc by the 9aaTADs

KNIGHT, Andrea, Josef HOUSER, Vilém JURÁŇ, Václav VYBÍHAL, Pavel FADRUS et. al.

Basic information

Original name

Targeting undruggable oncoproteins c-Myc and N-Myc by the 9aaTADs

Authors

KNIGHT, Andrea (203 Czech Republic, guarantor, belonging to the institution), Josef HOUSER (203 Czech Republic, belonging to the institution), Vilém JURÁŇ (203 Czech Republic, belonging to the institution), Václav VYBÍHAL (203 Czech Republic, belonging to the institution), Pavel FADRUS (203 Czech Republic, belonging to the institution), Martin SMRČKA (203 Czech Republic, belonging to the institution) and Martin PISKÁČEK (40 Austria, belonging to the institution)

Edition

Advanced Therapies 2023, 14-15 March 2023, ExCeL, London, 2023

Other information

Language

English

Type of outcome

Prezentace na konferencích

Field of Study

30109 Pathology

Country of publisher

United Kingdom of Great Britain and Northern Ireland

Confidentiality degree

není předmětem státního či obchodního tajemství

RIV identification code

RIV/00216224:14110/23:00130478

Organization unit

Faculty of Medicine

Keywords in English

c-Myc; N-Myc; 9aaTADs

Tags

Tags

International impact
Změněno: 21/3/2023 09:17, Mgr. Tereza Miškechová

Abstract

V originále

Targeting undruggable oncoproteins c-Myc and N-Myc by the 9aaTADs - Advanced Therapies 2023, 14-15 March 2023, ExCeL, London conference poster.

Links

LM2018127, research and development project
Name: Česká infrastruktura pro integrativní strukturní biologii (Acronym: CIISB)
Investor: Ministry of Education, Youth and Sports of the CR
NV19-05-00410, research and development project
Name: Úloha cytotoxických gamma-delta T buněk na terapeutické rezistenci a recidivě Glioblastoma Multiforme
Investor: Ministry of Health of the CR